ANI Pharmaceuticals, Inc.

NasdaqGM:ANIP Stock Report

Market Cap: US$1.9b

ANI Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ANIP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Sep 25SellUS$692,302Antonio PeraIndividual7,292US$94.94
25 Aug 25SellUS$229,087Matthew LeonardIndividual2,528US$90.62
22 Aug 25SellUS$160,609Krista DavisIndividual1,763US$91.10
21 Aug 25SellUS$9,036,008Esjay LlcCompany100,000US$90.44
20 Aug 25SellUS$486,426Antonio PeraIndividual5,421US$89.73
18 Aug 25SellUS$611,635Matthew LeonardIndividual6,937US$88.17
18 Aug 25SellUS$1,920,370Jeanne ThomaIndividual21,540US$89.76
15 Aug 25SellUS$801,450Patrick WalshIndividual9,000US$89.05
15 Aug 25SellUS$1,739,400Chad GassertIndividual20,000US$86.97
15 Aug 25SellUS$8,824,533Esjay LlcCompany100,000US$89.48
12 Aug 25SellUS$1,661,972Thomas HaugheyIndividual19,341US$85.93
12 Aug 25SellUS$508,191Ori GutwergIndividual5,873US$86.53
12 Aug 25SellUS$4,894,573Nikhil LalwaniIndividual56,960US$85.93
12 Aug 25SellUS$426,407Thomas RowlandIndividual4,975US$85.71
15 May 25SellUS$52,922Ori GutwergIndividual881US$60.07
14 May 25SellUS$241,800Christopher MutzIndividual4,000US$60.45
11 Mar 25SellUS$3,061,361MVP Capital PartnersCompany50,000US$61.29
05 Mar 25SellUS$305,040Ori GutwergIndividual5,084US$60.00
17 Dec 24SellUS$418,425Stephen CareyIndividual7,500US$55.79
26 Nov 24SellUS$202,942Nikhil LalwaniIndividual3,481US$58.30
15 Nov 24SellUS$375,050Christopher MutzIndividual6,500US$57.70

Insider Trading Volume

Insider Buying: ANIP insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANIP?
Owner TypeNumber of SharesOwnership Percentage
State or Government5,7620.0251%
Private Companies436,9201.9%
Individual Insiders1,635,3377.11%
Institutions20,916,90091%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 72.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.2%
BlackRock, Inc.
2,517,306US$228.1m-2.45%no data
6.17%
The Vanguard Group, Inc.
1,277,354US$115.7m8.12%no data
4.9%
MVP Capital Partners
1,014,381US$91.9m-12.9%100.0%
4.85%
Millennium Management LLC
1,003,876US$91.0m22.7%0.07%
4.17%
Global Alpha Capital Management Ltd.
862,090US$78.1m17.2%2.1%
3.46%
State Street Global Advisors, Inc.
716,117US$64.9m0.22%no data
3.38%
Deep Track Capital, LP
700,000US$63.4m0%1.15%
2.75%
Citadel Advisors LLC
569,630US$51.6m-21.3%0.04%
2.68%
Dimensional Fund Advisors LP
553,893US$50.2m-12.3%0.01%
2.58%
Ranger Investment Management, L.P.
534,233US$48.4m-6.54%3.42%
2.37%
William Blair Investment Management, LLC
490,536US$44.4m-7.14%0.05%
2.22%
UBS Asset Management AG
460,326US$41.7m47.2%no data
2.09%
Esjay Llc
431,920US$39.1m-31.7%no data
2.07%
Geode Capital Management, LLC
427,546US$38.7m-0.48%no data
2.05%
Macquarie Investment Management Business Trust
423,717US$38.4m-5.6%0.05%
1.99%
Nikhil Lalwani
411,219US$37.3m-12.2%no data
1.85%
Columbia Management Investment Advisers, LLC
382,595US$34.7m-2.11%0.01%
1.77%
Aberdeen Group Plc
365,933US$33.2m-12.7%0.02%
1.53%
Tang Capital Management, LLC
317,500US$28.8m0%1.08%
1.45%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
299,444US$27.1m529%0.01%
1.29%
Kennedy Capital Management LLC
267,030US$24.2m-6.89%0.55%
1.24%
Rubric Capital Management LP
257,669US$23.3m355%0.31%
1.24%
Charles Schwab Investment Management, Inc.
257,642US$23.3m0%no data
1.19%
Chad Gassert
246,841US$22.4m-7.5%no data
1.18%
Thompson, Siegel & Walmsley LLC
244,420US$22.1m3.12%0.27%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/02 07:03
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ANI Pharmaceuticals, Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Dewey SteadmanCanaccord Genuity
Timothy ChiangCapital One Securities, Inc.
Dana FlandersGuggenheim Securities, LLC